Castagna Olivier, Boussuges Alain, Nussbaum Eric, Marqueste Louis, Brisswalter Jeanick
I.M.N.S.S.A. B.P. 610-83800 Toulon Armées, Department of Ergonomics, University of Toulon Var, Toulon, France.
Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):270-7. doi: 10.1097/HJR.0b013e3282f009a9.
To assess the prevalence of peripheral arterial disease and its implications for exercise limitation in chronic obstructive pulmonary disease (COPD) patients.
One hundred and fifty-one moderate-to-severe COPD patients (forced expiratory volume in 1 s: 37+/-6 SD% predicted) and 73 healthy age-matched control individuals (divided into 31 smokers and 42 nonsmokers) participated in this study. All COPD patients were either exsmokers or current smokers and their tobacco-smoking history was similar to that of healthy smokers. To evaluate the existence of arterial disease, lower limb perfusion pressure impairment was assessed using the ankle brachial index, whereas arterial stiffness was assessed by the pulse wave velocity (PWV). The definition of peripheral arterial disease required an ankle brachial index value of 0.90 or less, whereas the PWV increment was considered to be a direct witness of arterial stiffness increase. A 6-min walk test was performed to assess physical exercise capacity.
Prevalence of peripheral arterial disease was higher in COPD patients than in healthy participants (81+/-3 SD; 49+/-5 SD and 9+/-2 SD%, respectively, in COPD, healthy smokers and nonsmokers). PWV mean values were significantly higher in COPD patients compared with healthy smokers and nonsmokers (10.3+/-2.1 SD m/s; 9.2+/-1.3 SD m/s and 8.7+/-2.2 SD m/s, respectively). The distance covered during the 6-min-walk test was associated positively with the degree of peripheral arterial disease (r=0.78; P=0.05) and negatively with the PWV values (r=-0.74; P=0.05). Not only tobacco-smoking history but also COPD severity was shown to influence these associations.
The effect of peripheral arterial disease on exercise intolerance in COPD seems to be considerable. Therefore, COPD patients participating in a pulmonary rehabilitation programme should profit from a systematic search for arterial disease. Arterial dysfunction has to be taken into account in the multidisciplinary treatment of these patients.
评估外周动脉疾病的患病率及其对慢性阻塞性肺疾病(COPD)患者运动受限的影响。
151例中重度COPD患者(1秒用力呼气容积:占预计值的37±6 SD%)和73例年龄匹配的健康对照者(分为31例吸烟者和42例非吸烟者)参与了本研究。所有COPD患者均为既往吸烟者或当前吸烟者,其吸烟史与健康吸烟者相似。为评估动脉疾病的存在情况,采用踝臂指数评估下肢灌注压损害,而通过脉搏波速度(PWV)评估动脉僵硬度。外周动脉疾病的定义要求踝臂指数值≤0.90,而PWV增加被认为是动脉僵硬度增加的直接证据。进行6分钟步行试验以评估身体运动能力。
COPD患者外周动脉疾病的患病率高于健康参与者(分别为81±3 SD%、49±5 SD%和9±2 SD%,COPD患者、健康吸烟者和非吸烟者)。与健康吸烟者和非吸烟者相比,COPD患者的PWV平均值显著更高(分别为10.3±2.1 SD m/s、9.2±1.3 SD m/s和8.7±2.2 SD m/s)。6分钟步行试验中行走的距离与外周动脉疾病程度呈正相关(r = 0.78;P = 0.05),与PWV值呈负相关(r = -0.74;P = 0.05)。不仅吸烟史,而且COPD严重程度也显示会影响这些关联。
外周动脉疾病对COPD患者运动不耐受的影响似乎相当大。因此,参加肺康复计划的COPD患者应从系统筛查动脉疾病中获益。在这些患者的多学科治疗中必须考虑动脉功能障碍。